There are currently two approved drugs to treat ALS: riluzole, which can extend lifespan by an average of a few months and has been on the market for 25 années, and the 2017-approved edaravone, which was shown in clinical trials to help patients function for longer into their disease


NBScience

organisme de recherche sous contrat

thérapie par cellules souches